149 related articles for article (PubMed ID: 27070807)
1. Methoxyisoflavones formononetin and isoformononetin inhibit the differentiation of Th17 cells and B-cell lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions.
Mansoori MN; Tyagi AM; Shukla P; Srivastava K; Dev K; Chillara R; Maurya R; Singh D
Menopause; 2016 May; 23(5):565-76. PubMed ID: 27070807
[TBL] [Abstract][Full Text] [Related]
2. Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis.
Srivastava K; Tyagi AM; Khan K; Dixit M; Lahiri S; Kumar A; Changkija B; Khan MP; Nagar GK; Yadav DK; Maurya R; Singh SP; Jain GK; Wahajuddin ; Trivedi R; Chattopadhyay N; Singh D
Phytomedicine; 2013 Apr; 20(6):470-80. PubMed ID: 23395215
[TBL] [Abstract][Full Text] [Related]
3. Formononetin reverses established osteopenia in adult ovariectomized rats.
Tyagi AM; Srivastava K; Singh AK; Kumar A; Changkija B; Pandey R; Lahiri S; Nagar GK; Yadav DK; Maurya R; Trivedi R; Singh D
Menopause; 2012 Aug; 19(8):856-63. PubMed ID: 22781783
[TBL] [Abstract][Full Text] [Related]
4. Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies.
Tyagi AM; Mansoori MN; Srivastava K; Khan MP; Kureel J; Dixit M; Shukla P; Trivedi R; Chattopadhyay N; Singh D
J Bone Miner Res; 2014 Sep; 29(9):1981-92. PubMed ID: 24677326
[TBL] [Abstract][Full Text] [Related]
5. Daidzein prevents the increase in CD4+CD28null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect.
Tyagi AM; Srivastava K; Sharan K; Yadav D; Maurya R; Singh D
PLoS One; 2011; 6(6):e21216. PubMed ID: 21731677
[TBL] [Abstract][Full Text] [Related]
6. Total extract and standardized fraction from the stem bark of Butea monosperma have osteoprotective action: evidence for the nonestrogenic osteogenic effect of the standardized fraction.
Pandey R; Gautam AK; Bhargavan B; Trivedi R; Swarnkar G; Nagar GK; Yadav DK; Kumar M; Rawat P; Manickavasagam L; Kumar A; Maurya R; Goel A; Jain GK; Chattopadhyay N; Singh D
Menopause; 2010; 17(3):602-10. PubMed ID: 20395887
[TBL] [Abstract][Full Text] [Related]
7. Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling.
Bhargavan B; Gautam AK; Singh D; Kumar A; Chaurasia S; Tyagi AM; Yadav DK; Mishra JS; Singh AB; Sanyal S; Goel A; Maurya R; Chattopadhyay N
J Cell Biochem; 2009 Oct; 108(2):388-99. PubMed ID: 19598169
[TBL] [Abstract][Full Text] [Related]
8. Dimethyloxalylglycine prevents bone loss in ovariectomized C57BL/6J mice through enhanced angiogenesis and osteogenesis.
Peng J; Lai ZG; Fang ZL; Xing S; Hui K; Hao C; Jin Q; Qi Z; Shen WJ; Dong QN; Bing ZH; Fu DL
PLoS One; 2014; 9(11):e112744. PubMed ID: 25394221
[TBL] [Abstract][Full Text] [Related]
9. IL-18BP is decreased in osteoporotic women: Prevents Inflammasome mediated IL-18 activation and reduces Th17 differentiation.
Mansoori MN; Shukla P; Kakaji M; Tyagi AM; Srivastava K; Shukla M; Dixit M; Kureel J; Gupta S; Singh D
Sci Rep; 2016 Sep; 6():33680. PubMed ID: 27649785
[TBL] [Abstract][Full Text] [Related]
10. Osteogenic actions of metoprolol in an ovariectomized rat model of menopause.
Zang Y; Tan Q; Ma X; Zhao X; Lei W
Menopause; 2016 Sep; 23(9):1019-25. PubMed ID: 27300117
[TBL] [Abstract][Full Text] [Related]
11. In silico estrogen-like activity and in vivo osteoclastogenesis inhibitory effect of Cicer arietinum extract.
Sayed AA; Elfiky AA
Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):29-39. PubMed ID: 29729691
[TBL] [Abstract][Full Text] [Related]
12. Formononetin, a methoxy isoflavone, enhances bone regeneration in a mouse model of cortical bone defect.
Singh KB; Dixit M; Dev K; Maurya R; Singh D
Br J Nutr; 2017 Jun; 117(11):1511-1522. PubMed ID: 28689509
[TBL] [Abstract][Full Text] [Related]
13. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency.
Ishimi Y; Miyaura C; Ohmura M; Onoe Y; Sato T; Uchiyama Y; Ito M; Wang X; Suda T; Ikegami S
Endocrinology; 1999 Apr; 140(4):1893-900. PubMed ID: 10098529
[TBL] [Abstract][Full Text] [Related]
14. Regulatory effect of traditional Chinese medicinal formula Zuo-Gui-Wan on the Th17/Treg paradigm in mice with bone loss induced by estrogen deficiency.
Lai N; Zhang Z; Wang B; Miao X; Guo Y; Yao C; Wang Z; Wang L; Ma R; Li X; Jiang G
J Ethnopharmacol; 2015 May; 166():228-39. PubMed ID: 25824592
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of substance P signaling aggravates the bone loss in ovariectomy-induced osteoporosis.
Zheng XF; Zhao ED; He JY; Zhang YH; Jiang SD; Jiang LS
Prog Biophys Mol Biol; 2016 Nov; 122(2):112-121. PubMed ID: 27237582
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of anti-IL-23 monotherapy versus combination therapy with anti-IL-17 in estrogen deficiency induced bone loss conditions.
Shukla P; Mansoori MN; Singh D
Bone; 2018 May; 110():84-95. PubMed ID: 29414600
[TBL] [Abstract][Full Text] [Related]
17. SOST Gene Inhibits Osteogenesis from Adipose-Derived Mesenchymal Stem Cells by Inducing Th17 Cell Differentiation.
You L; Chen L; Pan L; Peng Y; Chen J
Cell Physiol Biochem; 2018; 48(3):1030-1040. PubMed ID: 30041240
[TBL] [Abstract][Full Text] [Related]
18. Andrographolide modulates OPG/RANKL axis to promote osteoblastic differentiation in MC3T3-E1 cells and protects bone loss during estrogen deficiency in rats.
Tantikanlayaporn D; Wichit P; Suksen K; Suksamrarn A; Piyachaturawat P
Biomed Pharmacother; 2020 Nov; 131():110763. PubMed ID: 33152926
[TBL] [Abstract][Full Text] [Related]
19. Fast and long acting neoflavonoids dalbergin isolated from Dalbergia sissoo heartwood is osteoprotective in ovariectomized model of osteoporosis: Osteoprotective effect of Dalbergin.
Choudhary D; Kushwaha P; Gautam J; Kumar P; Verma A; Kumar A; Maurya SW; Siddiqui IR; Mishra PR; Maurya R; Trivedi R
Biomed Pharmacother; 2016 Oct; 83():942-957. PubMed ID: 27522257
[TBL] [Abstract][Full Text] [Related]
20. Combined effect of soy isoflavones and vitamin D3 on bone loss in ovariectomized rats.
Chang KL; Hu YC; Hsieh BS; Cheng HL; Hsu HW; Huang LW; Su SJ
Nutrition; 2013 Jan; 29(1):250-7. PubMed ID: 22858193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
